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Objective Rheumatoid arthritis (RA) is a chronic autoim-
mune disease of unknown cause which affects the ability of 
elderly people to work. There is strong evidence to suggest 
that infl ammatory mediators such as tumour necrosis factor α 
(TNFα) and interleukin 1 (IL1) have a critical role in the path-
ogenesis of RA. Biological treatment blocks pathological path-
ways in the actions of these proinfl ammatory cytokines. The 
aim of this study was to analyse concentrations of TNFα in 
blood serum and synovial fl uid in patients with RA to identify 
patient groups most suitable for anti-TNFα treatment.
Methods Blood serum and synovial fl uid from patients 
with RA and osteoarthritis (OA) at Pauls Stradins Clinical 
University Hospital Center of Rheumatology were selected for 
detection of TNFα from January 2005 to December 2007 by 
ELISA. Histiocyte/macrophage counts were detected in syno-
vial fl uid in the hospital laboratory. Statistical analyses were 
performed by the Student t test.
Results 29 patients with RA and 11 with OA participated in 
the study; 17 of the patients with RA had high disease activity 
(DAS >5.1) and 12 had medium disease activity (DAS ≤1). A 
statistically signifi cant difference was detected in TNFα lev-
els in the synovial fl uid of the RA group and the OA group 
(p=019), and in serum from the RA group versus the OA group 
(p=000154); medium activity RA group vs OA group TNFα in 
blood serum and synovial fl uid (p=007 and p=02) and high 
activity RA group vs OA group TNFα in blood serum and 
synovial fl uid (p<0.001 and p=001). The difference between 
high and medium RA activity groups in TNFα levels in serum 
and synovial fl uid was p=162 and p=0037. Histiocyte/mac-
rophage count in synovial fl uid differed in OA group vs RA 
medium disease activity group (p=02) and in OA vs RA high 
disease activity group (p=004), but in medium disease activity 
RA vs high disease activity RA group (p=58). 
Conclusion Further studies are needed to detect cytokines 
in blood serum and synovial fl uid for the use of one as a pos-
sible marker when choosing treatment for individual patients 
with RA.
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